P. Quinn William's Insider Trades & SAST Disclosures
P. Quinn William's most recent trade in Bolt Biotherapeutics Inc was a trade of 700,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on May 1, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern P. Quinn William.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Bolt Biotherapeutics Inc | William P. Quinn | Director, President, CEO and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2025 | 700,000 | 700,000 | - | - | Stock Option (Right to Buy) | |
| Bolt Biotherapeutics Inc | William P. Quinn | Director, President, CEO and CFO | Purchase of securities on an exchange or from another person at price $ 0.50 per share. | 01 May 2025 | 2,500 | 41,272 | - | 0.5 | 1,241 | Common Stock |
| Bolt Biotherapeutics Inc | William P. Quinn | Director, President, CEO and CFO | Purchase of securities on an exchange or from another person at price $ 0.64 per share. | 01 May 2025 | 2,500 | 38,772 | - | 0.6 | 1,594 | Common Stock |
| Bolt Biotherapeutics Inc | William P. Quinn | Director, President, CEO and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jul 2024 | 440,000 | 440,000 | - | - | Stock Option (Right to Buy) | |
| Bolt Biotherapeutics Inc | William P. Quinn | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 235,000 | 235,000 | - | - | Stock Option (Right to Buy) | |
| Bolt Biotherapeutics Inc | P. William Quinn | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.95 per share. | 12 Dec 2023 | 7,500 | 36,272 | - | 1.0 | 7,125 | Common Stock |
| Bolt Biotherapeutics Inc | P. William Quinn | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.78 per share. | 12 Dec 2023 | 2,500 | 28,772 | - | 0.8 | 1,955 | Common Stock |
| Bolt Biotherapeutics Inc | P. Quinn William | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 1.18 per share. | 12 Dec 2023 | 1,829 | 26,272 | - | 1.2 | 2,161 | Common Stock |
| Bolt Biotherapeutics Inc | William P. Quinn | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2023 | 250,000 | 250,000 | - | - | Stock Option (Right to Buy) | |
| Bolt Biotherapeutics Inc | William P. Quinn | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 1.64 per share. | 31 Dec 2022 | 2,500 | 22,654 | - | 1.6 | 4,101 | Common Stock |
| Bolt Biotherapeutics Inc | William P. Quinn | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 1.18 per share. | 31 Dec 2022 | 1,789 | 24,443 | - | 1.2 | 2,114 | Common Stock |
| Bolt Biotherapeutics Inc | William P. Quinn | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2022 | 210,000 | 210,000 | - | - | Stock Option (Right to Buy) | |
| Bolt Biotherapeutics Inc | William P. Quinn | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 4.72 per share. | 08 Dec 2021 | 5,000 | 20,154 | - | 4.7 | 23,575 | Common Stock |
| Bolt Biotherapeutics Inc | William P. Quinn | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 16.65 per share. | 08 Dec 2021 | 1,221 | 15,119 | - | 16.7 | 20,330 | Common Stock |
| Bolt Biotherapeutics Inc | William P. Quinn | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 4.63 per share. | 08 Dec 2021 | 35 | 15,154 | - | 4.6 | 162 | Common Stock |
| Bolt Biotherapeutics Inc | William P. Quinn | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 20.00 per share. | 09 Feb 2021 | 1,200 | 13,898 | - | 20 | 24,000 | Common Stock |
| Bolt Biotherapeutics Inc | William P. Quinn | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2021 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges